Barclays PLC Meridian Bioscience Inc Call Options Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $4,653 - $5,283	-300 Reduced 60.0%	200 $4,000
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $2,904 - $3,944	200 Added 66.67%	500 $9,000
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $169,290 - $186,390	-11,400 Reduced 97.44%	300 $4,000
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $56,580 - $68,880	-4,100 Reduced 25.95%	11,700 $186,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $140,760 - $165,240	10,200 Added 182.14%	15,800 $224,000
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $65,040 - $75,840	4,800 Added 600.0%	5,600 $78,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $10,760 - $11,480	800	800 $11,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.